Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC—A retrospective cohort study

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)59-65
Number of pages7
JournalLung Cancer
Volume134
DOIs
Publication statusPublished - Aug 2019

Fields of science

  • 301 Medical-Theoretical Sciences, Pharmacy
  • 302 Clinical Medicine

Cite this